Cargando…
Evaluating Effectiveness and Safety in Chronic Kidney Disease with Atrial Flutter Using an Anticoagulation Strategy
Background and objectives: Recent randomized trials of oral antithrombotic drugs with atrial flutter (AFL) excluded patients with renal impairment because of their increased risk of bleeding. To date, no relevant studies have assessed the effectiveness and safety of different antithrombotic drugs in...
Autores principales: | Wang, Ying-Ting, Chen, Chung-Yu, Bair, Ming-Jong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353883/ https://www.ncbi.nlm.nih.gov/pubmed/32481685 http://dx.doi.org/10.3390/medicina56060266 |
Ejemplares similares
-
The Comparative Effectiveness and Safety of Different Anticoagulation Strategies for Treatment of Left Atrial Appendage Thrombus in the Setting of Chronic Anticoagulation for Atrial Fibrillation or Flutter
por: Kołakowski, Karol, et al.
Publicado: (2021) -
Left Atrial Thrombus in Atrial Fibrillation/Flutter Patients in Relation to Anticoagulation Strategy: LATTEE Registry
por: Kapłon-Cieślicka, Agnieszka, et al.
Publicado: (2022) -
Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter
por: Fradley, Michael G., et al.
Publicado: (2020) -
Anticoagulation in Cancer Patients With Atrial Fibrillation or Atrial Flutter: Are There Gaps in Care?
por: Russo, Andrea M.
Publicado: (2020) -
Clinical outcomes of solitary atrial flutter patients using anticoagulation therapy: a national cohort study
por: Chen, Yung-Lung, et al.
Publicado: (2019)